FindTrial
Sign In

Understanding Dengue and Zika Viruses

Dengue and Zika Immunology and Genomics Multi-Country Network (DeZi Network) - DeZi

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110566
Enrollment
1400
Registered
2026-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Imperial College London
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants included in the SEFI cohort and the Acute febrile illness cohort

Exclusion criteria

Exclusion criteria: NOT APPLICABLE

Design outcomes

Primary

MeasureTime frame
Serological evidence of dengue and Zika transmissionTimepoint: baseline, 12 months—

Secondary

MeasureTime frame
NATimepoint: NA;Proportion of ZIKV IgG positives among the acute febrile cases identified in the cohort Proportion of DEN IgG positives in the cohort from paired samples collected one year apart Proportion of ZIKV IgG positives in the cohort from paired samples collected one year apart Timepoint: Baseline and one year apart—

Countries

India

Contacts

Public ContactBireshwar Sinha

Society for Applied Studies

deepak.more@sas.org.in9871197337

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026